Ardelyx Presents Data at DDW 2022 on IBSRELA (tenapanor), a First-In-Class Treatment for IBS-C in Adults.
In: ENP Newswire, 2022-05-25
Zeitungsartikel
Zugriff:
Titel: |
Ardelyx Presents Data at DDW 2022 on IBSRELA (tenapanor), a First-In-Class Treatment for IBS-C in Adults.
|
---|---|
Link: | |
Zeitschrift: | ENP Newswire, 2022-05-25 |
Veröffentlichung: | 2022 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|